Unexpected Effects of Methylphenidate in Attention-Deficit/Hyperactivity Disorder Reflect Decreases in Core/Secondary Symptoms and Physical Complaints Common to All Children
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Abstract Hypotheses concerning unexpected, psychostimulant-related effects reported in previous studies were examined by separating behavioral/physical complaints highly specific to methylphenidate (MPH) from those that (a) may mimic core/secondary symptoms of the disorder, or (b) are commonly reported by unmedicated children in the general population. Sixty-five children with attention-deficit/hyperactivity disorder (ADHD) participated in a double-blind, placebo-controlled, within-subject (crossover) experimental design and received a placebo and four MPH doses in counterbalanced order following baseline assessment. Behavioral and physical complaints were significantly higher under baseline relative to placebo and the four immediate-release MPH conditions (5 mg, 10 mg, 15 mg, and 20 mg) across three symptom categories: ADHD core/secondary symptoms; symptoms commonly reported in the general population, including unmedicated children with ADHD; and symptoms highly specific to MPH. No significant differences were found among active drug conditions. Past unexpected findings of psychostimulant effects in ADHD may be due to the inclusion of scale items that reflect core/secondary features of ADHD and normally occurring behavioral/physical complaints in children.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intraclass correlations: Uses in assessing rater reliability.
Shrout, P. E., & Fleiss, J. L. (1979) · Psychological Bulletin · doi:10.1037/0033-2909.86.2.420 · Cited by 24,532
Conners, C. K., Sitarenios, G., Parker, J. D. A., & Epstein, J. N. (1998) · Journal of Abnormal Child Psychology · doi:10.1023/a:1022606501530 · Cited by 678
(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1088 · Cited by 652
Chronis, A. M., Chacko, A., Fabiano, G. A., Wymbs, B. T., & Pelham, W. E. (2004) · Clinical Child and Family Psychology Review · doi:10.1023/b:ccfp.0000020190.60808.a4 · Cited by 454
Somatization in Children and Adolescents
Campo, J. V., & Fritsch, S. L. (1994) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199411000-00003 · Cited by 288 · cited 4×
“Literature reviews confirm that headaches represent the most commonly reported painful physical or behavioral symptom, and occur at least weekly in 10% to 30% of children in community samples (Campo and Fritsch 1994).”
InfluentialGREENHILL, L. L., SWANSON, J. M., VITIELLO, B., DAVIES, M., CLEVENGER, W., WU, M., ARNOLD, L. E., ABIKOFF, H. B., BUKSTEIN, O. G., CONNERS, C. K., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200102000-00012 · Cited by 287
Rapport, M. D., Chung, K.-M., Shore, G., & Isaacs, P. (2001) · Journal of Clinical Child & Adolescent Psychology · doi:10.1207/s15374424jccp3001_6 · Cited by 198 · cited 1×
“Core features of the disorder involve difficulties with attention, impulsiveness, and hyperactivity (APA 2000) and are hypothesized to affect behavioral and cognitive functioning to the extent that the latter are dependent upon the former for successful execution (Rapport et al. 2001).”
Self-citationPlacebo-Controlled Evaluation of Ritalin Side Effects
Ahmann, P. A., Waltonen, S. J., Theye, F. W., Olson, K. A., & Van Erem, A. J. (1993) · Pediatrics · doi:10.1542/peds.91.6.1101 · Cited by 178 · cited 4×
“…report that their children experience fewer behavioral (Gorman et al. 2006) and physical complaints such as daydreaming , irritability, anxiety, staring, and nail biting under MPH relative to placebo or baseline (Ahman et al. 1993; Findling et al. 2001; Greenhill et al. 2001b; Short et al. 2004).”
InfluentialSwanson, J. M., & Volkow, N. D. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00433-8 · Cited by 173
Faraone, S. V., Biederman, J., & Roe, C. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200210000-00005 · Cited by 91
Cited by
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
Storebø, O. J., Ramstad, E., Krogh, H. B., Nilausen, T. D., Skoog, M., Holmskov, M., Rosendal, S., Groth, C., Magnusson, F. L., Moreira-Maia, C. R., et al. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009885.pub2 · Cited by 347
Sonuga-Barke, E. J. S., Coghill, D., Wigal, T., DeBacker, M., & Swanson, J. (2009) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2009.0024 · Cited by 71
“However, it has been argued that some of these adverse events are due to preexisting problems already associated with ADHD prior to treatment (Efron et al. 1997; Rapport et al. 2008).”
Holmskov, M., Storebø, O. J., Moreira-Maia, C. R., Ramstad, E., Magnusson, F. L., Krogh, H. B., Groth, C., Gillies, D., Zwi, M., Skoog, M., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0178187 · Cited by 58
Koelch, M., Prestel, A., Singer, H., Schulze, U., & Fegert, J. M. (2010) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2008.0114 · Cited by 37
“Both parents and children’s concerns about being exposed to psycho-pharmacological medications are essential to any understanding of how they make treatment decisions (Tait et al. 2003a; dosReis and Myers 2008; Rapport et al. 2008; Thorell and Dahlstrom 2008).”
Metadata
- Authors
- Rapport, M. D., Kofler, M. J., Coiro, M. M., Raiker, J. S., Sarver, D. E., & Alderson, R. M.
- Venue
- Journal of Child and Adolescent Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2008-06
- Volume
- 18
- Issue
- 3
- Pages
- 237-247
- ISSN
- 1044-5463 (ISSN-L)
- 1557-8992
- OpenAlex
- W2066748657
- Cited by
- 18
- References
- 13
- FWCI
- 1.25
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.